The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 2, 2005, Pages 234-240

  Ozkinay, Erdinc ^a   Terek, Mustafa Cosan ^a   Yayci, Murat ^b   Kaiser, Renato ^c   Grob, Philipp ^c   Tuncay, Gungor ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b A Ibrahim Pharmaceut Prod Indust   (Turkey)

^c Medinova Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRIOL; FLUCONAZOLE; GYNOFLOR; KETOCONAZOLE; METRONIDAZOLE; PLACEBO; POVIDONE IODINE;

ADULT; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LEUKOCYTE; MAJOR CLINICAL STUDY; NAUSEA; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRICHOMONIASIS; VAGINA DISCHARGE; VAGINA FLORA; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; COMBINED MODALITY THERAPY; COMMUNICABLE DISEASES; DOUBLE-BLIND METHOD; ESTRIOL; FEMALE; HUMANS; LACTOBACILLUS; MIDDLE AGED; PILOT PROJECTS; TABLETS; TREATMENT OUTCOME; VAGINA; VAGINAL DISEASES;

EID: 13244252365     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00329.x     Document Type: Article

References (38)

1. Blackwell AL, Phillips I, Fox AR, Barlow D. Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological and therapeutic findings. Lancet 1983;17:1379-1382.
2. Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis. Role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med 1978;298:1429-1434.
3. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-211.
4. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br J Obstet Gynaecol 2002;109:34-43.
5. Hay PE, Ugwumadu A, Chowns J. Sex, thrush and bacterial vaginosis. Int J STD AIDS 1997;8:603-608.
6. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-256.
7. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996;174:1058-1063.
8. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993;16:S273-S281.
9. 2-generating lactobacilli. J Infect Dis 1991;164:94-100.
10. Sobel JD. Is there a protective role for vaginal flora? Curr Infect Dis Rep 1999;1:379-383.
11. Boris S, Suarez JE, Vazquez F, Barbes C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998;66:1985-1989.
12. Osset J, Bartolome RM, Garcia E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001;183: 485-491.
13. Brown WJ. Microbial ecology of the normal vagina. In: Hafez ESE, Evans TN, editors. The Human Vagina. New York: Elsevier/North Holland Biomedical Press, 1978:407-422.
14. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990;12:856-872.
15. Sjöberg I, Cajander S, Rylander E. Morphometric characteristics of the vaginal epithelium during the menstrual cycle. Gynecol Obstet Invest 1988;26:136-144.
16. Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:455-459.
17. Liss RH, Letourneau RJ. Fungispecificity of fluconazole against Candida albicans. Mycopathologia 1989;108:173-178.
18. Ross RA, Lee ML, Onderdonk AB. Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol 1995;86:925-930.
19. Feiks A, Grünberger W. Treatment of atrophic vaginitis: does topical application allow a reduction in the oestrogen dose? Gynäkol Rundsch 1991;31:268-271.
20. Kanne B, Jenny J. Local administration of low-dosed estriol and viable Lactobacillus acidophilus in the post-menopausal period. Gynäkol Rundsch 1991;31:1-8.
21. Parent D, Bossens M, Bayot D, et al. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol. Arzneimittelforschung 1996;46:68-73.
22. Lauritzen C, Graf F, Mucha M. Restoration of the physiological vaginal environment with doederlein bacteria and estriol. Frauenarzt 1984;4:5-8.
23. Petersen EE. Bedeutung der Laktobazillen als Normalflora. Gynäkologe 1985;18:128-130.
24. Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Am J Obstet Gynecol 1992;166:938-944.
25. Schroeder K. Zur Pathogenese und Klinik des vaginalen Fluors. Zentralbl Gynäkol 1921;38:1350.
26. Collins EB, Hardt P. Inhibition of Candida albicans by Lactobacillus acidophilus. J Dairy Sci 1980;63:830-832.
27. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and Stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995;23:32-45.
28. Larsson PG. Treatment of bacterial vaginosis. Int J STD AIDS 1992; 3:239-247.
29. Hillier SL, Holmes KK. Bacterial vaginosis. In: Holmes KK, Mardh PA, Sparling PF, et al., editors. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999:563-587.
30. Sobel JD. Treatment of vaginal Candida infections. Expert Opin Pharmacother 2002;3:1059-1065.
31. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet 2000;71:21-27.
32. Elsner P, Hartmann AA. Gardnerella vaginalis in the male upper genital tract: a possible source of reinfection of the female partner. Sex Transm Dis 1987;14:122-123.
33. Barbes C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDS 1999;13:747-751.
34. Boris S, Barbes C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect 2000;2:543-546.
35. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73:437S-443S.
36. Hilton E, Rindos P, Isenberg HD. Lactobacillus GG vaginal suppositories and vaginitis. J Clin Microbiol 1995;33:1433.
37. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996;5:593-596.
38. Bandera Gonzalez B, Conde de Vargas BI, Gonzalez Avalos GA, Toledo Medina A. Treatment of non-specific cervicovaginitis with a lyophilised preparation of lactobacilli and oestriol. Prensa Med Mex 1977;XLII(1-2):91-95.